University of California San Francisco
Helen Diller Family Comprehensive Cancer Center
Kieuhoa Tran Vo, MD, MAS

Kieuhoa Tran Vo, MD, MAS

Assistant Professor, Department of Pediatrics, UCSF Benioff Children’s Hospital

Cancer Center Program Memberships

Pediatric Malignancies

Research Summary

My research career is focused on the development of novel prognostic and predictive biomarkers and incorporation of these biomarkers into new clinical trials, working towards more effective and less toxic therapies in children and young adults with solid tumors.

Education

University of Notre Dame, Notre Dame, IN B.S. 2000-2004 Biological Sciences, Minor in Anthropology
Indiana University School of Medicine, Indianapolis, IN M.D. 2004-2008 Medicine
Nationwide Children’s Hospital, Ohio State University School of Medicine, Columbus, OH Residency 2008-2011 Pediatrics
UCSF Benioff Children’s Hospital, University of California, San Francisco School of Medicine, San Francisco, CA Fellowship 2012-2015 Pediatric Hematology/Oncology
University of California, San Francisco, Department of Epidemiology and Biostatistics M.A.S. 2013-2015 Clinical Research


Professional Experience

  • 2008-2009
    Internship, Pediatrics, Nationwide Children’s Hospital, Ohio State University School of Medicine, Columbus, OH
  • 2009-2011
    Medical Residency, Pediatrics, Nationwide Children’s Hospital, Ohio State University School of Medicine, Columbus, OH
  • 2012-2015
    Clinical Fellow, Division of Pediatric Hematology/Oncology, UCSF Benioff Children’s Hospital, University of California, San Francisco School of Medicine, San Francisco, CA
  • 2011-2012
    Clinical Assistant Professor, Department of Emergency Medicine, Nationwide Children’s Hospital, Ohio State University School of Medicine, Columbus, OH
  • 2015-present
    Assistant Professor, Department of Pediatrics, UCSF Benioff Children’s Hospital, University of California, San Francisco School of Medicine, San Francisco, CA

Honors & Awards

  • 2008
    Indiana University School of Medicine Tina Kwan Scholarship Award in Pediatrics
  • 2013-present
    Developmental Therapeutics Scholar, Alex’s Lemonade Stand Foundation Center of Excellence Grant

Selected Publications

  1. Vo KT, Karski EE, Nasholm NM, Allen S, Hollinger F, Gustafson WC, Long-Boyle JR, Shiboski S, Matthay KK, DuBois SG. Phase 1 study of sirolimus in combination with oral cyclophosphamide and topotecan in children and young adults with relapsed and refractory solid tumors. Oncotarget. 2016 Oct 25.
    View on PubMed
  2. Huibregtse KE, Vo KT, DuBois SG, Fetzko S, Neuhaus J, Batra V, Maris JM, Weiss B, Marachelian A, Yanik GA, Matthay KK. Incidence and risk factors for secondary malignancy in patients with neuroblastoma after treatment with (131)I-metaiodobenzylguanidine. Eur J Cancer. 2016 Aug 26; 66:144-152.
    View on PubMed
  3. Vo KT, Matthay KK, DuBois SG. Targeted antiangiogenic agents in combination with cytotoxic chemotherapy in preclinical and clinical studies in sarcoma. Clin Sarcoma Res. 2016; 6:9.
    View on PubMed
  4. Davenport JR, Vo KT, Goldsby R, West DC, DuBois SG. Conditional Survival and Predictors of Late Death in Patients With Ewing Sarcoma. Pediatr Blood Cancer. 2016 Jun; 63(6):1091-5.
    View on PubMed
  5. Vo KT, Edwards JV, Epling CL, Sinclair E, Hawkins DS, Grier HE, Janeway KA, Barnette P, McIlvaine E, Krailo MD, Barkauskas DA, Matthay KK, Womer RB, Gorlick RG, Lessnick SL, Mackall CL, DuBois SG. Impact of Two Measures of Micrometastatic Disease on Clinical Outcomes in Patients with Newly Diagnosed Ewing Sarcoma: A Report from the Children's Oncology Group. Clin Cancer Res. 2016 Jul 15; 22(14):3643-50.
    View on PubMed
  6. Thompson D, Vo KT, London WB, Fischer M, Ambros PF, Nakagawara A, Brodeur GM, Matthay KK, DuBois SG. Identification of patient subgroups with markedly disparate rates of MYCN amplification in neuroblastoma: A report from the International Neuroblastoma Risk Group project. Cancer. 2016 Mar 15; 122(6):935-45.
    View on PubMed
  7. Vo KT, Matthay KK, Neuhaus J, London WB, Hero B, Ambros PF, Nakagawara A, Miniati D, Wheeler K, Pearson AD, Cohn SL, DuBois SG. Clinical, biologic, and prognostic differences on the basis of primary tumor site in neuroblastoma: a report from the international neuroblastoma risk group project. J Clin Oncol. 2014 Oct 1; 32(28):3169-76.
    View on PubMed
  8. Vo KT, Grooms L, Klima J, Holland-Hall C, O'Brien SH. Menstrual bleeding patterns and prevalence of bleeding disorders in a multidisciplinary adolescent haematology clinic. Haemophilia. 2013 Jan; 19(1):71-5.
    View on PubMed
  9. Joo J, Christensen L, Warner K, States L, Kang HG, Vo K, Lawlor ER, May WA. GLI1 is a central mediator of EWS/FLI1 signaling in Ewing tumors. PLoS One. 2009; 4(10):e7608.
    View on PubMed

Go to UCSF Profiles, powered by CTSI